Clinical Efficacy of Vasakadi Ghan Vati in Management of Hypertensive Retinopathy, Randomised Open Labelled Anti-oxidant Controlled Prospective Study.

R A Podar Medical Ayurvedic College0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1)Willing to give written consent to participate in the study.
•2)Age 20-70 years.
•3)Both sexes.
•4)Known patient of essential hypertension presenting signs of hypertensive retinopathy on fundal examination.
•5)Subject with hypertensive retinopathy: Keith Wegner Barker Grade 1, 2 and 3.
•6)Subject with systolic blood pressure less than 180 mm of Hg. and diastolic blood pressure less than 120 mm of Hg.
•7)Hypertensive patient complaining of dimness of vision.

•1)Age less than 20 years and more than 70 years.
•2)Secondary hypertension and Severe or stage • hypertension (Blood pressure more than equal to 180/110 mm of Hg.)
•3)Presence of fundus alteration which did not result from arterial hypertension.
•4)Presence of cardio-vascular disease other than hypertension and collagen disease.
•5)Presence of hypertensive emergencies and urgencies (diastolic blood pressure more than equal to 130 mm of Hg. or severe blood pressure with target organ damage.)and hypertension related disorders.
•6)Diabetes mellitus.
•7)Thyroid disease.
•8)Current abuse of alcohol or other drug.
•9)Mental incapacitance.
•10)Unwillingness.
•11)Dropouts.

发起方

R A Podar Medical Ayurvedic College